These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 32217938)
1. Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference. Mehta N; Bhangui P; Yao FY; Mazzaferro V; Toso C; Akamatsu N; Durand F; Ijzermans J; Polak W; Zheng S; Roberts JP; Sapisochin G; Hibi T; Kwan NM; Ghobrial M; Soin A Transplantation; 2020 Jun; 104(6):1136-1142. PubMed ID: 32217938 [TBL] [Abstract][Full Text] [Related]
2. Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference. Berenguer M; Burra P; Ghobrial M; Hibi T; Metselaar H; Sapisochin G; Bhoori S; Kwan Man N; Mas V; Ohira M; Sangro B; van der Laan LJW Transplantation; 2020 Jun; 104(6):1143-1149. PubMed ID: 32217940 [TBL] [Abstract][Full Text] [Related]
3. Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions. Pavel MC; Fuster J World J Gastroenterol; 2018 Aug; 24(32):3626-3636. PubMed ID: 30166858 [TBL] [Abstract][Full Text] [Related]
4. Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference. Hibi T; Rela M; Eason JD; Line PD; Fung J; Sakamoto S; Selzner N; Man K; Ghobrial RM; Sapisochin G Transplantation; 2020 Jun; 104(6):1131-1135. PubMed ID: 32217939 [TBL] [Abstract][Full Text] [Related]
5. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience. Lee KW; Yi NJ; Suh KS Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825 [TBL] [Abstract][Full Text] [Related]
6. Living donor liver transplantation for hepatocellular carcinoma. Lee SG; Moon DB Recent Results Cancer Res; 2013; 190():165-79. PubMed ID: 22941020 [TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for HCC: its role: Eastern and Western perspectives. Hwang S; Lee SG; Belghiti J J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):443-8. PubMed ID: 19885638 [TBL] [Abstract][Full Text] [Related]
9. The ILTS Consensus Conference on Transplant Oncology: Setting the Stage. Sapisochin G; Hibi T; Ghobrial M; Man K Transplantation; 2020 Jun; 104(6):1119-1120. PubMed ID: 32217941 [No Abstract] [Full Text] [Related]
10. Living donor liver transplantation for hepatocellular carcinoma: the impact of neo-adjuvant treatments on the long term results. Di Sandro S; Giacomoni A; Slim A; Lauterio A; Mangoni I; Mihaylov P; Pirotta V; Aseni P; De Carlis L Hepatogastroenterology; 2012; 59(114):505-10. PubMed ID: 22353516 [TBL] [Abstract][Full Text] [Related]
11. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses. Wong TCL; Ng KKC; Fung JYY; Chan AAC; Cheung TT; Chok KSH; Dai JWC; Lo CM Ann Surg Oncol; 2019 May; 26(5):1454-1462. PubMed ID: 30737669 [TBL] [Abstract][Full Text] [Related]
13. Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation. Goldaracena N; Gorgen A; Doyle A; Hansen BE; Tomiyama K; Zhang W; Ghanekar A; Lilly L; Cattral M; Galvin Z; Selzner M; Bhat M; Selzner N; McGilvray I; Greig PD; Grant DR; Sapisochin G J Hepatol; 2019 Apr; 70(4):666-673. PubMed ID: 30630009 [TBL] [Abstract][Full Text] [Related]
14. Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation. Mehta N; Dodge JL; Hirose R; Roberts JP; Yao FY Am J Transplant; 2019 Aug; 19(8):2210-2218. PubMed ID: 30861298 [TBL] [Abstract][Full Text] [Related]
15. Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study. Azoulay D; Audureau E; Bhangui P; Belghiti J; Boillot O; Andreani P; Castaing D; Cherqui D; Irtan S; Calmus Y; Chazouillères O; Soubrane O; Luciani A; Feray C Ann Surg; 2017 Dec; 266(6):1035-1044. PubMed ID: 27617853 [TBL] [Abstract][Full Text] [Related]
16. The Impact of Allocation Changes on Patients with Hepatocellular Carcinoma. Yohanathan L; Heimbach JK Clin Liver Dis; 2020 Nov; 24(4):657-663. PubMed ID: 33012451 [TBL] [Abstract][Full Text] [Related]
17. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: the controversies continue. Lee HS Dig Dis; 2007; 25(4):296-8. PubMed ID: 17960062 [TBL] [Abstract][Full Text] [Related]
18. Expansion of the criteria for living donor liver transplantation for hepatocellular carcinoma. Lee HW; Suh KS Curr Opin Organ Transplant; 2016 Apr; 21(2):231-7. PubMed ID: 26918880 [TBL] [Abstract][Full Text] [Related]
19. Transplant benefit for patients with hepatocellular carcinoma. Vitale A; Volk M; Cillo U World J Gastroenterol; 2013 Dec; 19(48):9183-8. PubMed ID: 24409046 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Intention-to-Treat Benefit of Living Donation in Patients With Hepatocellular Carcinoma Awaiting a Liver Transplant. Lai Q; Sapisochin G; Gorgen A; Vitale A; Halazun KJ; Iesari S; Schaefer B; Bhangui P; Mennini G; Wong TCL; Uemoto S; Lin CC; Mittler J; Ikegami T; Yang Z; Frigo AC; Zheng SS; Soejima Y; Hoppe-Lotichius M; Chen CL; Kaido T; Lo CM; Rossi M; Soin AS; Finkenstedt A; Emond JC; Cillo U; Lerut JP JAMA Surg; 2021 Sep; 156(9):e213112. PubMed ID: 34259797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]